2P domain K+ channels: novel pharmacological targets for volatile general anesthetics.
Patel
Amanda J
AJ
Institut de Pharmacologie Moléculaire et Cellulaire, CNRS-UMR6097, 660 route des Lucioles, Sophia Antipolis, 06560 Valbonne, France.
Honore
Eric
E
D018681:Anesthetics, General / Q000494:pharmacology*; D000818:Animals; D005727:Ganglia, Spinal / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009419:Nerve Tissue Proteins / Q000187:drug effects; D015221:Potassium Channels / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D024683:Potassium Channels, Tandem Pore Domain; D017434:Protein Structure, Tertiary; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism
D018681:Anesthetics, General; C503438:KCNK10 protein, human; C410295:KCNK5 protein, human; C498655:KCNK9 protein, human; C503444:Kcnk10 protein, rat; D009419:Nerve Tissue Proteins; D015221:Potassium Channels; D024683:Potassium Channels, Tandem Pore Domain; C103742:potassium channel protein TREK-1; C420132:potassium channel subfamily K member 3